BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16010429)

  • 1. Doxorubicin induces apoptosis with profile of large-scale DNA fragmentation and without DNA ladder in anaplastic thyroid carcinoma cells via histone hyperacetylation.
    Rho JH; Kang DY; Park KJ; Choi HJ; Lee HS; Yee SB; Yoo YH
    Int J Oncol; 2005 Aug; 27(2):465-71. PubMed ID: 16010429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
    Kim TH; Yoo YH; Kang DY; Suh H; Park MK; Park KJ; Kim SH
    Int J Oncol; 2009 May; 34(5):1353-62. PubMed ID: 19360347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells.
    Roh MS; Kim CW; Park BS; Kim GC; Jeong JH; Kwon HC; Suh DJ; Cho KH; Yee SB; Yoo YH
    Apoptosis; 2004 Sep; 9(5):583-9. PubMed ID: 15314286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.
    Catalano MG; Fortunati N; Pugliese M; Poli R; Bosco O; Mastrocola R; Aragno M; Boccuzzi G
    J Endocrinol; 2006 Nov; 191(2):465-72. PubMed ID: 17088416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
    Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
    Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells.
    Kang J; Zhang D; Chen J; Liu Q; Lin C
    Toxicol In Vitro; 2005 Mar; 19(2):173-82. PubMed ID: 15649630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
    Wetzel M; Premkumar DR; Arnold B; Pollack IF
    J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A induces apoptosis of p815 mastocytoma cells in histone acetylation- and mitochondria-dependent fashion.
    Yee SB; Kim MS; Baek SJ; Kim GC; Yoo KS; Yoo YH; Park BS
    Int J Oncol; 2004 Nov; 25(5):1431-6. PubMed ID: 15492835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.
    Bártová E; Pacherník J; Harnicarová A; Kovarík A; Kovaríková M; Hofmanová J; Skalníková M; Kozubek M; Kozubek S
    J Cell Sci; 2005 Nov; 118(Pt 21):5035-46. PubMed ID: 16254244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
    Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
    Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
    Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
    J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
    Rahim R; Strobl JS
    Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of human leukemic cell lines to the histone deacetylase inhibitor, trichostatin A.
    Ninios YP; Sekeri-Pataryas KE; Sourlingas TG
    Leuk Res; 2010 Jun; 34(6):786-92. PubMed ID: 19782399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells.
    Kumar KS; Sonnemann J; Beck JF
    Oncol Rep; 2006 Nov; 16(5):1047-52. PubMed ID: 17016591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J; Du C; Kang J; Wang J
    Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
    El-Khoury V; Gomez D; Liautaud-Roger F; Trussardi-Régnier A; Dufer J
    Cytometry A; 2004 Dec; 62(2):109-17. PubMed ID: 15517561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A.
    Lu MC; Du YC; Chuu JJ; Hwang SL; Hsieh PC; Hung CS; Chang FR; Wu YC
    Arch Toxicol; 2009 Feb; 83(2):121-9. PubMed ID: 18709356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.